Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20193126rdf:typepubmed:Citationlld:pubmed
pubmed-article:20193126lifeskim:mentionsumls-concept:C0015576lld:lifeskim
pubmed-article:20193126lifeskim:mentionsumls-concept:C0597357lld:lifeskim
pubmed-article:20193126lifeskim:mentionsumls-concept:C1512505lld:lifeskim
pubmed-article:20193126lifeskim:mentionsumls-concept:C0668195lld:lifeskim
pubmed-article:20193126lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:20193126pubmed:issue2lld:pubmed
pubmed-article:20193126pubmed:dateCreated2010-3-2lld:pubmed
pubmed-article:20193126pubmed:abstractTextThe function of macrophage inhibitory cytokine-1 (MIC-1) in cancer remains controversial, and its signaling pathways remain poorly understood. In this study, we demonstrate that MIC-1 induces the transactivation of EGFR, ErbB2, and ErbB3 through the activation of c-Src in SK-BR-3 breast cells. MIC-1 induced significant phosphorylation of EGFR at Tyr845, ErbB2 at Tyr877, and ErbB3 at Tyr1289 as well as Akt and p38, Erk1/2, and JNK mitogen-activated protein kinases (MAPKs). Treatment of SK-BR-3 cells with MIC-1 increased the phosphorylation level of Src at Tyr416, and induced invasiveness of those cells. Inhibition of c-Src activity resulted in the complete abolition of MIC-1-induced phosphorylation of the EGFR, ErbB2, and ErbB3, as well as invasiveness and matrix metalloproteinase (MMP)-9 expression in SK-BR-3 cells. Collectively, these results show that MIC-1 may participate in the malignant progression of certain cancer cells through the activation of c-Src, which in turn may transactivate ErbB-family receptors.lld:pubmed
pubmed-article:20193126pubmed:languageenglld:pubmed
pubmed-article:20193126pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20193126pubmed:citationSubsetIMlld:pubmed
pubmed-article:20193126pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20193126pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20193126pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20193126pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20193126pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20193126pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20193126pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20193126pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20193126pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20193126pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20193126pubmed:statusMEDLINElld:pubmed
pubmed-article:20193126pubmed:monthFeblld:pubmed
pubmed-article:20193126pubmed:issn1976-670Xlld:pubmed
pubmed-article:20193126pubmed:authorpubmed-author:LeeJeong-Hyun...lld:pubmed
pubmed-article:20193126pubmed:authorpubmed-author:LeeHansooHlld:pubmed
pubmed-article:20193126pubmed:authorpubmed-author:ParkYun...lld:pubmed
pubmed-article:20193126pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20193126pubmed:volume43lld:pubmed
pubmed-article:20193126pubmed:ownerNLMlld:pubmed
pubmed-article:20193126pubmed:authorsCompleteYlld:pubmed
pubmed-article:20193126pubmed:pagination91-6lld:pubmed
pubmed-article:20193126pubmed:meshHeadingpubmed-meshheading:20193126...lld:pubmed
pubmed-article:20193126pubmed:meshHeadingpubmed-meshheading:20193126...lld:pubmed
pubmed-article:20193126pubmed:meshHeadingpubmed-meshheading:20193126...lld:pubmed
pubmed-article:20193126pubmed:meshHeadingpubmed-meshheading:20193126...lld:pubmed
pubmed-article:20193126pubmed:meshHeadingpubmed-meshheading:20193126...lld:pubmed
pubmed-article:20193126pubmed:meshHeadingpubmed-meshheading:20193126...lld:pubmed
pubmed-article:20193126pubmed:meshHeadingpubmed-meshheading:20193126...lld:pubmed
pubmed-article:20193126pubmed:meshHeadingpubmed-meshheading:20193126...lld:pubmed
pubmed-article:20193126pubmed:meshHeadingpubmed-meshheading:20193126...lld:pubmed
pubmed-article:20193126pubmed:meshHeadingpubmed-meshheading:20193126...lld:pubmed
pubmed-article:20193126pubmed:meshHeadingpubmed-meshheading:20193126...lld:pubmed
pubmed-article:20193126pubmed:meshHeadingpubmed-meshheading:20193126...lld:pubmed
pubmed-article:20193126pubmed:meshHeadingpubmed-meshheading:20193126...lld:pubmed
pubmed-article:20193126pubmed:meshHeadingpubmed-meshheading:20193126...lld:pubmed
pubmed-article:20193126pubmed:meshHeadingpubmed-meshheading:20193126...lld:pubmed
pubmed-article:20193126pubmed:year2010lld:pubmed
pubmed-article:20193126pubmed:articleTitleMacrophage inhibitory cytokine-1 transactivates ErbB family receptors via the activation of Src in SK-BR-3 human breast cancer cells.lld:pubmed
pubmed-article:20193126pubmed:affiliationDepartments of Biochemistry and College of Natural Sciences, Kangwon National University, Chuncheon 200-701, Korea.lld:pubmed
pubmed-article:20193126pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20193126pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:9518entrezgene:pubmedpubmed-article:20193126lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:20193126lld:entrezgene